Alexander Luft
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers 18
- Colorectal Cancer Treatments and Studies 10
- Lung Cancer Research Studies 9
- Cancer Treatment and Pharmacology 4
-
- Lung Cancer Treatments and Mutations 25
- Lung Cancer Diagnosis and Treatment 7
- Immunology top 10%
- Epidemiology top 5%
- Neuroendocrine Tumor Research Advances 3
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 5
- Co-authors
- Martin ReckIgor BondarenkoHuiling LüRaju Titus ChackoPiotr SerwatowskiJean-Marie CuillerotThomas J. LynchFabrice Barlési
- Journals
- Journal of Clinical Oncology (10 papers)Annals of Oncology (10 papers)Journal of Thoracic Oncology (7 papers)
- Partner nations
- RussiaUnited StatesGermany
In The Last Decade
Alexander Luft
33 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 71
- Oncology 2.0k
- Pulmonary and Respiratory Medicine 1.0k
- Immunology 362
- Epidemiology 560
- Cancer Research 163
Countries citing papers authored by Alexander Luft
This map shows the geographic impact of Alexander Luft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Luft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Luft more than expected).
Fields of papers citing papers by Alexander Luft
This network shows the impact of papers produced by Alexander Luft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Luft. The network helps show where Alexander Luft may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alexander Luft, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | Pembrolizumab Plus Chemotherapy in Squamous Non–Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Studybreakdown → | 2023 | 233 |
| 3 | 2023 | 4 | |
| 4 | 2023 | 3 | |
| 5 | Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non–Small-Cell Lung Cancer: The Phase III POSEIDON Studybreakdown → | 2022 | 238 |
| 6 | 2022 | 8 | |
| 7 | 2021 | 18 | |
| 8 | 2020 | 17 | |
| 9 | 2020 | 1 | |
| 10 | 2019 | 43 | |
| 11 | 2019 | 57 | |
| 12 | 2019 | 7 | |
| 13 | 2019 | 0 | |
| 14 | 2018 | 4 | |
| 15 | 2018 | 4 | |
| 16 | 2016 | 1 | |
| 17 | Efficacy and safety of necitumumab continuation therapy in phase 3 SQUIRE study | 2015 | 1 |
| 18 | 2015 | 24 | |
| 19 | Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-disease-small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trialbreakdown → | 2012 | 500 |
| 20 | 2011 | 74 |
About Alexander Luft
Alexander Luft is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Gastroenterology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 35 papers that have together received 2.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (25 papers), Cancer Immunotherapy and Biomarkers (18 papers), Colorectal Cancer Treatments and Studies (10 papers), Lung Cancer Research Studies (9 papers), Lung Cancer Diagnosis and Treatment (7 papers), Cancer Genomics and Diagnostics (5 papers), Cancer Treatment and Pharmacology (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). The work is most often cited by research in Oncology (2.0k citations), Pulmonary and Respiratory Medicine (1.0k citations), Immunology (362 citations), Epidemiology (560 citations) and Cancer Research (163 citations). Alexander Luft has collaborated with scholars based in Russia, United States and Germany. Frequent co-authors include Martin Reck, Igor Bondarenko, Huiling Lü, Raju Titus Chacko, Piotr Serwatowski, Jean-Marie Cuillerot, Thomas J. Lynch, Fabrice Barlési, Martin Sebastian and Julien Mazières. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal of Thoracic Oncology, Lung Cancer and Clinical Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.